Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 6, 2022
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
Tue, April 5, 2022
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
Arlinda Lee Maintained (BNTX) at Strong Buy with Decreased Target to $300 on, Apr 5th, 2022
Arlinda Lee of Canaccord Genuity, Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $450 to $300 on, Apr 5th, 2022.
Arlinda has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 3 agree with Arlinda's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $200 on, Friday, April 1st, 2022
- Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $217 on, Tuesday, February 1st, 2022
This is the rating of the analyst that currently disagrees with Arlinda
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $339 on, Wednesday, February 23rd, 2022
